228 related articles for article (PubMed ID: 17895861)
1. One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.
Barcia C; Jimenez-Dalmaroni M; Kroeger KM; Puntel M; Rapaport AJ; Larocque D; King GD; Johnson SA; Liu C; Xiong W; Candolfi M; Mondkar S; Ng P; Palmer D; Castro MG; Lowenstein PR
Mol Ther; 2007 Dec; 15(12):2154-63. PubMed ID: 17895861
[TBL] [Abstract][Full Text] [Related]
2. Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors.
Thomas CE; Schiedner G; Kochanek S; Castro MG; Lowenstein PR
Hum Gene Ther; 2001 May; 12(7):839-46. PubMed ID: 11339900
[TBL] [Abstract][Full Text] [Related]
3. Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.
Xiong W; Candolfi M; Kroeger KM; Puntel M; Mondkar S; Larocque D; Liu C; Curtin JF; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2008 Feb; 16(2):343-51. PubMed ID: 18180781
[TBL] [Abstract][Full Text] [Related]
4. A rapid protocol for construction and production of high-capacity adenoviral vectors.
Jager L; Hausl MA; Rauschhuber C; Wolf NM; Kay MA; Ehrhardt A
Nat Protoc; 2009; 4(4):547-64. PubMed ID: 19373227
[TBL] [Abstract][Full Text] [Related]
5. Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver.
Jager L; Ehrhardt A
Hum Gene Ther; 2009 Aug; 20(8):883-96. PubMed ID: 19364285
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus expression of IL-1 and NF-kappaB inhibitors does not inhibit acute adenoviral-induced brain inflammation, but delays immune system-mediated elimination of transgene expression.
Stone D; Xiong W; Williams JC; David A; Lowenstein PR; Castro MG
Mol Ther; 2003 Sep; 8(3):400-11. PubMed ID: 12946313
[TBL] [Abstract][Full Text] [Related]
7. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
Sayedahmed EE; Kumari R; Shukla S; Hassan AO; Mohammed SI; York IA; Gangappa S; Sambhara S; Mittal SK
Vaccine; 2018 Oct; 36(45):6744-6751. PubMed ID: 30266488
[TBL] [Abstract][Full Text] [Related]
8. New insights into stability of recombinant adenovirus vector genomes in mammalian cells.
Rauschhuber C; Noske N; Ehrhardt A
Eur J Cell Biol; 2012 Jan; 91(1):2-9. PubMed ID: 21440326
[TBL] [Abstract][Full Text] [Related]
9. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
[TBL] [Abstract][Full Text] [Related]
10. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
11. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.
Lemiale F; Kong WP; Akyürek LM; Ling X; Huang Y; Chakrabarti BK; Eckhaus M; Nabel GJ
J Virol; 2003 Sep; 77(18):10078-87. PubMed ID: 12941918
[TBL] [Abstract][Full Text] [Related]
12. Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency.
Petrof BJ; Lochmüller H; Massie B; Yang L; Macmillan C; Zhao JE; Nalbantoglu J; Karpati G
Hum Gene Ther; 1996 Oct; 7(15):1813-26. PubMed ID: 8894673
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
[TBL] [Abstract][Full Text] [Related]
14. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.
Wang WC; Sayedahmed EE; Mittal SK
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560730
[TBL] [Abstract][Full Text] [Related]
15. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases.
Thomas CE; Schiedner G; Kochanek S; Castro MG; Löwenstein PR
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7482-7. PubMed ID: 10840055
[TBL] [Abstract][Full Text] [Related]
16. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses.
Xiong W; Goverdhana S; Sciascia SA; Candolfi M; Zirger JM; Barcia C; Curtin JF; King GD; Jaita G; Liu C; Kroeger K; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
J Virol; 2006 Jan; 80(1):27-37. PubMed ID: 16352528
[TBL] [Abstract][Full Text] [Related]
17. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.
Chen HH; Mack LM; Choi SY; Ontell M; Kochanek S; Clemens PR
Hum Gene Ther; 1999 Feb; 10(3):365-73. PubMed ID: 10048389
[TBL] [Abstract][Full Text] [Related]
18. Quantification of high-capacity helper-dependent adenoviral vector genomes in vitro and in vivo, using quantitative TaqMan real-time polymerase chain reaction.
Puntel M; Curtin JF; Zirger JM; Muhammad AK; Xiong W; Liu C; Hu J; Kroeger KM; Czer P; Sciascia S; Mondkar S; Lowenstein PR; Castro MG
Hum Gene Ther; 2006 May; 17(5):531-44. PubMed ID: 16716110
[TBL] [Abstract][Full Text] [Related]
19. Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.
Muhammad AK; Puntel M; Candolfi M; Salem A; Yagiz K; Farrokhi C; Kroeger KM; Xiong W; Curtin JF; Liu C; Lawrence K; Bondale NS; Lerner J; Baker GJ; Foulad D; Pechnick RN; Palmer D; Ng P; Lowenstein PR; Castro MG
Clin Pharmacol Ther; 2010 Aug; 88(2):204-13. PubMed ID: 20164833
[TBL] [Abstract][Full Text] [Related]
20. Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.
Kreppel F; Kochanek S
J Virol; 2004 Jan; 78(1):9-22. PubMed ID: 14671083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
